Articles of the Month
Videos
Articles
Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection
Jansson, M.K., Neuber, K., Rudolf, H., Podbielski, A., Virchow, J.C. and Warnke, P. Allergy. First published: 23 November 2021
Mast cells partly contribute to allergic enteritis development: findings in two different mast cell-deficient mice
Blanco-Pérez, F., Gonzalez-Menendez, I., Stassen, M., et al. Allergy. First published: 22 November 2021
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis
Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021
The Ccl17 gene encoding TARC is synergistically transactivated by PU.1 and IRF4 driven by the mammalian common promoter in dendritic cells
Ito, N., Sakata, F., Hachisu, M., et al. Allergy. First published: 22 November 2021
Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma
Mishra, A., Majid, D., Kandikattu, H.K., Yadavalli, C.S. and Upparahalli Venkateshaiah, S. Allergy. First published: 20 November 2021
Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps
Ma, Y., Wei, Y., Liu, X., et al. Allergy. First published: 16 November 2021
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
Maurer, M., Giménez-Arnau, A., Bernstein, J.A., et al. Allergy. First published: 13 November 2021
The emerging pathogen Paecilomyces variotii – a novel and important fungal allergen source
Pfeiffer, S., Raith, M., Pascal, M., et al. Allergy. First published: 13 November 2021
Immune-epithelial barrier interactions mediate intestinal adaptation to diverse diets
Avino, G., Riggioni, C. and Comberiati, P. Allergy. First published: 12 November 2021
Epithelial barrier dysfunction in ocular allergy
Singh, N., Diebold, Y., Sahu, S.K. and Leonardi, A. Allergy. First published: 10 November 2021
Proposal of 0.5mg of protein /100g of processed food as threshold for voluntary declaration of food allergen traces in processed food – a first step in an initiative to better inform patients and avoid fatal allergic reactions - A GA²LEN position paper
Zuberbier, T., Dörr, T., Aberer, W., et al. Allergy. First published: 06 November 2021
Impaired skin barrier and allergic sensitization in early infancy
Wärnberg Gerdin, S, Lie, A, Asarnoj, A, et al. Allergy. First published: 05 November 2021
Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis
Luo, L, Luo, Y, Xu, J, et al. Allergy. First published: 05 November 2021
Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota
Zhao, Y., Chen, J., Hao, Y., et al. Allergy. First published: 04 November 2021
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study
Trubiano, J.A., Vogrin, S., Copaescu, A., et al. Allergy. First published: 04 November 2021
GATA-3 and T-bet as diagnostic markers of non-esophageal eosinophilic gastrointestinal disease
Neely, J.L., Reimers, A., Taylor, S., et al. Allergy. First published: 04 November 2021
Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults (Running title: Component-resolved diagnostics for hazelnut allergy in Dutch adults)
Lyons, S.A., Welsing, P.M.J., Hakobyan, M., et al. Allergy. First published: 03 November 2021
Citations: 3335
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Citations: 2330
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478
Citations: 1328
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 1300
A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force
Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824
Citations: 885
Position Paper - Allergen Standardization and Skin-Tests
Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54
Citations: 794
Allergenic pollen and pollen allergy in Europe
D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990
Citations: 760
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316
Citations: 757
The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887
Citations: 664
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948
Citations: 617
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025
Citations: 1590
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 350
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 179
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 167
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 164
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 77
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 56
Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827
Citations: 55
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 52
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection
Jansson, M.K., Neuber, K., Rudolf, H., Podbielski, A., Virchow, J.C. and Warnke, P. Allergy. First published: 23 November 2021
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis
Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021
Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways
Aliee, H., Massip, F., Qi, C., et al. Allergy. First published: 26 October 2021
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021
RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19
Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021
What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders
Maggi, E, Azzarone, BG, Canonica, GW, Moretta, L. Allergy. First published: 28 September 2021
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Juniors,
Despite these challenging times, EAACI is keeping up with several scientific activities, aiming to being able to meet you all in person soon! The next upcoming appointments are:
- EAACI Pediatric Allergy and Asthma Meeting (PAAM) digital 2021:
It will take place on 12–13 November 2021, in an interactive hybrid format that will allow you to take part in scientific discussions both on-site both from the safety of your home through an innovative and highly interactive concept. The aim is to share new research and findings with internationally renowned experts in the common effort to come up with solutions to the most pressing challenges in the evolving pediatric field.
You can find any information about PAAM by clicking here
- 20th Immunology Winter School on Basic Immunology Research in Allergy and Clinical Immunology:
It will take place from 27 to 30 January 2022, in Semmering (Austria) in an interactive hybrid format. The event will gather 70 young researchers, PhD students and junior postdoc, active in the field of allergy, asthma, clinical immunology/immune deficiency with a focus on basic and/or clinical immunology. The participants will be selected on the basis of the quality of their submitted abstracts.
You can submit your abstract until the 7th of November by clicking here
We look forward to seeing you at our incoming activities and working together to ensure that the highest standards of care are implemented and shared within our specialty.
Best regards,
The Junior Member Assembly
